Skip to main content
Kimo Stine, MD, Pediatric Hematology & Oncology, Little Rock, AR, UAMS Medical Center

KimoStineMD

Pediatric Hematology & Oncology Little Rock, AR

Professor, Pediatrics, University of Arkansas COM

Dr. Stine is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stine's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1985 - 1989
  • University of Kansas School of Medicine
    University of Kansas School of MedicineResidency, Pediatrics, 1982 - 1985
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1982

Certifications & Licensure

  • AR State Medical License
    AR State Medical License 1991 - 2025
  • NC State Medical License
    NC State Medical License 1989 - 1992
  • LA State Medical License
    LA State Medical License 1989 - 1991
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patien...
    Kimo Stine, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • ASH 2020: Update for the Alta Study, a Phase 1/2 Gene Therapy Trial of Giroctocogene Fitelparvovec (SB-525) in Adults with Severe Hemophilia A
    ASH 2020: Update for the Alta Study, a Phase 1/2 Gene Therapy Trial of Giroctocogene Fitelparvovec (SB-525) in Adults with Severe Hemophilia ADecember 18th, 2020

Professional Memberships

Hospital Affiliations